A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Registration Number
- NCT05250817
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 501
Inclusion Criteria
The following is the inclusion criteria for pretest interviews and final online survey.
Participants:
- Must be 18 years of age or older
- Must be a US resident.
- Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.
Exclusion Criteria
- Not applicable
Other protocol-defined inclusion/exclusion criteria apply
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Set of relative preference weights for all attribute levels included in the Discrete Choice Experiment (DCE) At Baseline Respondents' baseline understanding of attribute descriptions At Baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
RTI Health Solutions
🇺🇸Research Triangle Park, North Carolina, United States